Delivery Order SPE2DB22D2211-SPE2DB25FRVKC
Award Date
4/16/25
Potential Completion Date
4/17/25
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $8,144.52, is for the delivery of 4567491061 - ACTEMRA 400 MG/20 ML VIAL 20ML. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The ultimate completion date is March 7, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,754.13, is a delivery order for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, a biologic medication used to treat certain autoimmune conditions. The contract has an ultimate completion date of November 7, 2024 and is a firm fixed price arrangement. This contract award is not associated with any...
This federal contract award, valued at $2,471.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA 200 MG/10 ML VIAL 10ML, a specialty pharmaceutical product, to support federal healthcare programs. The contract is a Firm Fixed Price Delivery Order, with a performance period ending on February 19, 2025. No set-aside designation was used for this award....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ACTEMRA 200 MG/10 ML VIAL 10ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,471.52 and a period of performance through May 21, 2025. This award is not associated with a set-aside program and represents an open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,324.73 firm fixed-price delivery order is for the supply of ACTEMRA 200 MG/10 ML VIAL 10ML, a medical product. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,571.72 firm fixed price delivery order contract, awarded on October 16, 2024, is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, a specialty medication. The contract has an ultimate completion date of October 17, 2024 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $4,275.83 firm fixed-price delivery order is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, a pharmaceutical product. This contract is not set-aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $30,179.46. The contract is a firm fixed price delivery order with a period of performance through February 19, 2025. This award is part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,960.91 firm fixed-price delivery order is for the supply of ACTEMRA 200 MG/10 ML VIAL 10ML, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $1,438.92, is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication. This is a delivery order contract with a firm fixed price pricing type, with an ultimate completion date of March 17, 2025. The contract does not have a set-aside designation, indicating open...